Medicinal Cannabis Matters: Friday Roundup - 13 February 2026
This week’s Medicinal Cannabis Matters brings together powerful patient stories and emerging data that continue to shape the future of medicinal cannabis care in the UK. From lived experience in the Scottish Borders to national media coverage and new survey findings among cancer patients, the focus remains firmly on quality of life and informed access.
How a Patient from Galashiels is Managing Chronic Pain
A baker from Galashiels has shared how prescribed medicinal cannabis has helped him manage long-term pain and improve his day-to-day functioning. Speaking openly about his experience, he describes finding relief after conventional treatments failed to provide consistent benefit.
Stories like this are important. They remind us that behind policy debates and clinical research are individuals navigating chronic conditions, often after years of limited options. When prescribed appropriately and monitored by specialist clinicians, medicinal cannabis can offer a regulated pathway for patients who have not found success elsewhere.
Medicinal Cannabis Makes Real-World Difference to Patients' Lives
A recent BBC report highlights the real-world difference prescribed medicinal cannabis can make to patients' lives.
The article features the story of a six-year-old girl who takes prescribed medical cannabis to help control her epileptic seizures. Since starting treatment, her family reports a significant reduction in seizure frequency, illustrating the profound impact cannabis-based medicines can have in certain severe and treatment-resistant conditions.
Alongside this personal story, the report examines the wider landscape of NHS prescribing, which remains limited despite legalisation in 2018. For many families and patients, specialist clinics like Medicann continue to provide a regulated and clinically supervised pathway to treatment when other options have been exhausted.
Cancer Patients Report Symptom Relief
New survey data suggests that many cancer patients using medicinal cannabis report improvements in symptoms such as pain, nausea, sleep disturbance and anxiety. While surveys do not replace clinical trials, they provide valuable real-world insight into patient experience and perceived benefit.
Cancer care is complex, and medicinal cannabis is not a cure. However, for some patients, it may form part of a broader symptom management plan under medical supervision. Continued data collection and research are essential in building a stronger evidence base and guiding responsible prescribing.
This week's stories reflect a continued shift towards openness and evidence. Patients are speaking out, media outlets are reporting more widely and data is being gathered and analysed. The conversation around medicinal cannabis in the UK is becoming more informed and more grounded in real-world experience.
At Medicann, our focus remains clear on safe access, thorough assessment and ongoing clinical support. For those living with chronic or treatment-resistant conditions, understanding your options is the first step.
If you would like to explore whether medicinal cannabis may be appropriate for you, you can check your eligibility online in just two minutes.
Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.